Recent Headlines
Curemeta LLC to Present at IBC Life Science 2015
Curemeta LLC, a Boston-based oncology biotech, will be at the IBC Life Science Conference in San Francisco. They will be presenting data on their ADCs which target pluripotent cancer stem cells. - May 16, 2015 - Curemeta LLC
ValueCentricIQ Unveils Innovative Mobile App
The app delivers comprehensive insights, industry trends, and benchmarking tools to the Pharmaceutical IndustryVCIQ Industry Benchmark app is now available on iOS, Android, and Desktop devices - May 13, 2015 - ValueCentric
Brightest Minds Convene to Discuss Research Initiatives
Leading childhood brain tumor researchers from the United States and Canada are gathering today for two Pediatric Brain Tumor Foundation-led scientific meetings in San Diego. This year’s Translating Discoveries to Cure the Kids meeting will bring together 20 experts for a think-tank... - May 08, 2015 - Pediatric Brain Tumor Foundation
Motorcyclists Ride for PBTF in California, North Carolina
Motorcyclists at Ride for Kids events in California and North Carolina over the weekend raised $220,868 for the Pediatric Brain Tumor Foundation. More than 1,200 motorcyclists gathered on May 3 for the Los Angeles and N.C. Triangle Ride for Kids events to honor local brain tumor survivors Amanda,... - May 06, 2015 - Pediatric Brain Tumor Foundation
Curemeta LLC to Present at PEGS Boston
Curemeta LLC, a Boston-based biotech focused on developing antibody drug conjugate therapies for metastatic cancers, announced that they will be presenting their data on novel ADC therapies at the essential Protein Engineering Summit (PEGS) taking place at the Seaport World Trade Center in Boston... - May 03, 2015 - Curemeta LLC
Join the Pediatric Brain Tumor Foundation for Brain Tumor Awareness Month
Brain Tumor Awareness Month in May honors Stars like Brieanan Jerome, who was diagnosed when she was 10 months old. Every day in May on social media, the Pediatric Brain Tumor Foundation's Starlight stories will shine a light on someone affected by a childhood brain tumor. In the days leading up... - May 02, 2015 - Pediatric Brain Tumor Foundation
Creative Biomart Launches an Intuitive New Website Design to Enhance User Experience
Creative Biomart, the leading company in the supply of diagnostic antigens and antibodies, pharmaceutical enzymes, diagnostic enzymes, and high-quality recombinant proteins has launched an intuitive new website design as well as coupon promotion. - April 29, 2015 - Creative Biomart
Texas, New Mexico Riders Help Kids with Brain Tumors
Motorcyclists who attended the Albuquerque and Houston Ride for Kids events over the weekend raised $204,491 for the Pediatric Brain Tumor Foundation. More than 450 motorcyclists gathered on April 26 to honor local brain tumor survivors Andres, Ceasar, Garrett, Javier, Joshua, Kaitlyn, Malcolm,... - April 29, 2015 - Pediatric Brain Tumor Foundation
MoBiTec and GORYO Chemical Ink Distribution Agreement to Sell High-End Calcium Indicators and Cancer-Selective Fluorescent Imaging Probes
MoBiTec GmbH, Germany, focused on selling products for life science and fluorescence applications, has entered into a distribution agreement with GORYO, Japan. Together with GORYO, MoBiTec will continue to expand its portfolio of premier brands. - April 29, 2015 - MoBiTec GmbH
Paras Biopharmaceuticals Finland Oy Selected as First Finnish Company to Present at Cavendish Global
Paras Biopharmaceuticals Finland Oy, an upcoming biopharmaceutical manufacturing company for biosimilars and therapeutic peptides, announced today that it has been selected to present at the Cavendish Global Health Impact Forum taking place 10th - 14th May in La Jolla, California, USA. The purpose... - April 28, 2015 - Paras Biopharmaceuticals Finland Oy
PBTF Supports Research Into Personalized Medicine
The Pediatric Brain Tumor Foundation is investing in a network of children’s hospitals that are researching personalized medicine for children with brain tumors. The Pacific Pediatric Neuro-Oncology Consortium, or PNOC, was formed to provide children with brain tumors access to innovative... - April 25, 2015 - Pediatric Brain Tumor Foundation
Princeton Student Invents Hangover Cure Named Thrive+
While studying neuroscience at Princeton University, then Sophomore Brooks Powell discovered a way to prevent hangovers. He invented Thrive+ and it is now sold online and in select retailers. - April 21, 2015 - Thrive+
Karcinolys Announces the Formation of Pancrealys, Its New Pancreatic Cancer Division
Pancreatic cancer selected as first indication for Targeted HSV-1 derived oncolytic virus Myb34.5. - April 17, 2015 - Karcinolys
Glaucoma Visual Fields Improve Following Stem Cell Treatment
MD Stem Cells reports peripheral vision improvement in glaucoma. - April 12, 2015 - MD Stem Cells
AdvantaPure(R) Publishes White Papers on Clean Room Fluid Transfer, Tubing Selection and Container Closures; Topics Address Issues for Pharma and Biopharma Manufacturers
New from tubing and Single-Use System manufacturer AdvantaPure are three white papers focusing on fluid transfer in pharmaceutical and biopharmaceutical applications. The papers focus on incorporating Single-Use practices for clean room fluid transfer, tubing selection, and the importance of container closures. Developed by the company’s application engineers, the reports offer real world examples of critical fluid transfer applications. - April 09, 2015 - AdvantaPure
The State of California Invests in VIRUN® NutraBIOsciences™; VIRUN® Receives Two More Patent Grants in China While Premiering Esolv® Vitamin E Encapsulator
The State of California has invested in VIRUN, Inc., this along with two newly granted patents in China that correlate with the release of VIRUN’s Esolv®. Algatech to premiere their AstaPure® branded Astaxanthin in a new clear, water soluble powder utilizing VIRUN’s Esolv®, clean label claim encapsulator, for beverage and liquid applications. - April 07, 2015 - VIRUN
Navigen Announces Phase II NIH SBIR Award for the Advancement of Ebola Virus Therapy
Navigen, Inc., a Utah-based drug discovery and development company, has received an NIH award for $2.9 million to develop its anti-Ebola virus D-peptide. Navigen's compound targets a region of the Ebola virus that is 100% conserved and thus should be effective against all strains of virus. - March 24, 2015 - Navigen, Inc.
AveXis EU Ltd. Granted SME Status by the European Medicines Agency
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the European Medicines Agency (EMA) has granted AveXis’ wholly owned European subsidiary,... - March 21, 2015 - AveXis Inc.
Recursion Pharmaceuticals Announces Funding Support for Ataxia-Telangiectasia
Recursion today announced a grant from the AT-Children's Project to advance it's innovative drug discovery work towards identifying novel treatments for ataxia-telangiectasia, a brutal childhood genetic disease. - March 20, 2015 - Recursion Pharmaceuticals
Peptineo Announces Appointment of Dr. Panganiban to Peptineo to Serve as Chief Science Officer
Peptineo is pleased to announce that Nito Panganiban, Ph.D., has been named Chief Science Officer at Peptineo. Dr. Panganiban will be responsible for cultivating core research capabilities, establishing product development roadmaps, and for communicating with key scientific and customer communities... - March 20, 2015 - Peptineo
PBTF Salutes Honda for 25th Year of Support
The Pediatric Brain Tumor Foundation is grateful to American Honda for 25 years of support in the fight against childhood brain tumors. When the company’s Honda Riders Club of America became the presenting sponsor of the PBTF’s Ride for Kids program in 1991, the event was able to... - March 20, 2015 - Pediatric Brain Tumor Foundation
AdvantaPure(R) to Highlight Single-Use Fluid Transfer Innovations at Spring Tradeshows; Includes Appearances in the U.S. and Europe
AdvantaPure will showcase its high purity tubing and Single-Use products at a number of trade shows this spring. Scheduled events will take place in California, New York and Germany. The company will feature its molded manifold assemblies, which are designed to reduce leaks and other risks. Also on hand will be its silicone tubing, AdvantaFlex TPE tubing, AdvantaPass Single-Use fluid transfer technology, BioClosure container closures, process hoses, and hose tracking and identification methods. - March 19, 2015 - AdvantaPure
Creative Bioarray Introduces Hek 293 Cells for Specific Research Needs
The US-based biotech company, Creative Bioarray has recently Introduced Hek 293 cells into its cell repository for meeting customers’ specific research needs. - March 16, 2015 - Creative Bioarray
National Brain Tumor Society Statement on Harold Varmus, MD, Director of the National Cancer Institute and Nobel Laureate
Largest brain tumor nonprofit in the U.S. thanks Harold Varmus for his service and leadership. - March 14, 2015 - National Brain Tumor Society
China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech
China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015 - Braasch Biotech LLC
ValueCentric Launches Expansion of Channel Data Visualizations with ValueTrak 7.0
Includes anticipated charting and analytic enhancements for pharmaceutical manufacturers. - March 11, 2015 - ValueCentric
PBTF Names Early Career Development Grant Awardees
The Pediatric Brain Tumor Foundation has awarded its first Early Career Development grants to three up-and-coming pediatric brain tumor researchers studying medulloblastoma and ependymoma. These awards support talented pediatric brain tumor researchers who are early in their career. The recipients... - March 05, 2015 - Pediatric Brain Tumor Foundation
AveXis Announces the Formation of Its European Subsidiary, AveXis EU, Ltd.
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced the formation of its EU-based wholly-owned subsidiary, AveXis EU, Ltd. The subsidiary will allow AveXis... - February 27, 2015 - AveXis Inc.
AnaSpec Launches Industry’s First Amino Acid Pre-loaded Hydrazide Resins
AnaSpec is pleased to announce the launch of the first commercially available Amino Acid Pre-loaded Hydrazide Resins. Native Chemical Ligation (NCL) has been one of the most used bioconjugation methodologies for synthesis of macromolecules. NCL requires a peptide thioester and another peptide... - February 25, 2015 - AnaSpec, EGT Group
Newsletter XVIII Released | MoBiTec GmbH, Germany
The latest edition of the MoBiTec Newsletter is now available for customers to view. It comprises products for genomics & imaging, in vitro diagnostics and assays, interaction screening, magnetic beads as tool in proteomics, and Non-UV transilluminator. - February 18, 2015 - MoBiTec GmbH
Viradux Research, Ltd. Has Expanded the Number of International Shipping Destinations Worldwide and Has Enhanced Its Anti-Herpetic Cream and Lipbalm
Viradux Research, Ltd. announced today that it has expanded the number of international shipping destinations worldwide. Additionally, Viradux has just released to market an improved formulation of its leading anti-herpetic cream Viradux-AU. - February 13, 2015 - viradux
AnaSpec Launches Industry’s First Assay for Measuring Matriptase Activity
AnaSpec is pleased to announce the launch of the first commercially available kit for measuring the activity of Matriptase, a protease implicated in carcinogenesis. The SensoLyte® Rh110 Matriptase Assay Kit provides a convenient assay for screening of Matriptase inhibitors and activators or... - February 13, 2015 - AnaSpec, EGT Group
AdvantaPure(R) Invests in Training Its Team Members; Partners with Worcester Polytechnic Institute for Biomanufacturing Training
Employees from AdvantaPure, a manufacturer of high purity tubing and Single-Use components for biopharma manufacturing, recently received customized training at the Biomanufacturing Education and Training Center of Worcester Polytechnic Institute in Worcester, Mass. The training involved classroom and hands-on instruction to teach the employees about the equipment and processes used by their customers in their pharmaceutical and biopharmaceutical manufacturing operations. - February 07, 2015 - AdvantaPure
MoBiTec to Offer New Transcreener UDP2 TR-FRET Assay, Manufactured by BellBrook Labs
Just like the existing UDP2 FP assay, the TR-FRET assay provides sensitive detection of glycosyltransferases and other UDP-producing enzymes. The new Transcreener UDP2 TR-FRET Assay will better serve a growing need for robust, HTS-proven glycosyltransferase assays for drug discovery. - January 31, 2015 - MoBiTec GmbH
HiLyte™ Your Antibodies Using One Universal Reagent
AnaSpec is pleased to announce the release of a product line of recombinant Protein A, conjugated with HiLyte™ Fluor dyes or Biotin. This universal reagent can be used to detect antibodies from different species, such as human, rabbit, mouse, rat and others. Protein A is available as labeled... - January 30, 2015 - AnaSpec, EGT Group
Creative Bioarray Releases New Stem Cell Products
The US-based biotech company, Creative Bioarray has recently added hundred of kinds of stem cell products to its cell product repository. - January 24, 2015 - Creative Bioarray
VIRUN® NutraBIOsciences™ to Present at BEVERAGE INNOVATION 2015 on February 4th – Hear VIRUN talk Innovation from Water to Beer
VIRUN to present the latest-and-greatest at Beverage Innovation 2015, presented to you by FoodNavigator-USA and BeverageDaily. From cognitive waters containing Phosphatidylserine, DHA Omega-3 and weight-loss waters with high levels of Resveratrol and Curcumin that help regulate blood sugar, to heart-healthy waters containing 1000mg Phytosterols and 680mg EPA DHA Omega-3. From water to beer, raw material to finished product, VIRUN is your solutions-based resource. - January 20, 2015 - VIRUN
CHI Scientific Releases PrimaCell™ Protocols for Culturing More Than 300 Types of Primary Cells to Speed Biological Discoveries
Brings Standardized Methods to the Research Scientist, Greatly Reducing the Time Needed to Prepare and Culture Critical Tissue and Organ Cells. - January 16, 2015 - CHI Scientific Inc
Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines
Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015 - Braasch Biotech LLC
AveXis Closes Its Series C Financing Round with Deerfield Management and Roche Venture Fund
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced it has completed a $10 million financing round led by Deerfield Management and Roche Venture Fund. In... - January 08, 2015 - AveXis Inc.
Good News - Creative Biomart Newly Introduced Fucose-Free Protein Expression System
Creative Biomart, a world leading biotech company that specializes in providing advanced tolls for protein expression and purification, today has officially announced its release of novel service--Fucose-free Protein Expression System. According to its official speaker, this service is supported by... - January 07, 2015 - Creative Biomart
Creative Biomart Launches Special Promotion for Christmas and New Year
Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its... - December 25, 2014 - Creative Biomart
Creative Biomart Newly Introduced Multiplex Protein Detect Assay
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein... - December 21, 2014 - Creative Biomart
Ethan Jostad Foundation Gives Gift of Childhood Cancer Research
Non-Profit charity donates to pediatric cancer research for most difficult to treat childhood cancers. - December 20, 2014 - Ethan Jostad Foundation for Childhood Cancer
Experimentica Ltd. Licenses Akimba Mouse Model for Diabetic Retinopathy from Lions Eye Institute, Australia
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd
Brand New IHC Services Are Available Now at Creative Diagnostics
Creative Diagnostics has launched immunohistochemistry (IHC) and in situ hybridization (ISH) laboratory services for diagnostic and research purposes. - December 19, 2014 - Creative Diagnostics
Advanced Cancer Therapeutics’ PFK-158 Featured in CEO/CFO Magazine; Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been featured in the December 15, 2014 issue of CEO/CFO Magazine in which ACT President and CEO Randall B. Riggs discusses PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. - December 17, 2014 - Advanced Cancer Therapeutics
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung Cancer EMQN Report
The European Molecular Genetics Quality Network (EMQN) is an independent organization based in the UK that promotes improvement in the quality of genetic testing by ensuring that diagnostic molecular genetic laboratory test results are accurate, reliable, and comparable. - December 11, 2014 - MoBiTec GmbH
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.